IRIDEX Corporation (IRIX)
USD 0.88
(-7.25%)
USD 0.88
(-7.25%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 34.43 Million USD | -18.57% |
| 2022 | 42.29 Million USD | -13.14% |
| 2021 | 48.68 Million USD | 74.07% |
| 2020 | 27.96 Million USD | -19.66% |
| 2019 | 34.81 Million USD | -16.46% |
| 2018 | 41.67 Million USD | 0.06% |
| 2017 | 41.64 Million USD | -13.5% |
| 2016 | 48.14 Million USD | 15.11% |
| 2015 | 41.82 Million USD | 0.01% |
| 2014 | 41.81 Million USD | 24.17% |
| 2013 | 33.67 Million USD | 16.48% |
| 2012 | 28.91 Million USD | -10.07% |
| 2011 | 32.14 Million USD | 10.02% |
| 2010 | 29.22 Million USD | 3.28% |
| 2009 | 28.29 Million USD | 0.23% |
| 2008 | 28.22 Million USD | -39.5% |
| 2007 | 46.65 Million USD | 16.12% |
| 2006 | 40.17 Million USD | -2.26% |
| 2005 | 41.1 Million USD | 5.14% |
| 2004 | 39.09 Million USD | 9.08% |
| 2003 | 35.83 Million USD | 4.57% |
| 2002 | 34.27 Million USD | 1.43% |
| 2001 | 33.78 Million USD | -3.53% |
| 2000 | 35.02 Million USD | 7.22% |
| 1999 | 32.66 Million USD | 15.02% |
| 1998 | 28.4 Million USD | 6.37% |
| 1997 | 26.7 Million USD | 12.66% |
| 1996 | 23.7 Million USD | 270.31% |
| 1995 | 6.4 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 34.09 Million USD | -1.0% |
| 2024 Q2 | 31.24 Million USD | -8.34% |
| 2023 Q4 | 34.43 Million USD | -1.47% |
| 2023 Q2 | 36.93 Million USD | -9.86% |
| 2023 Q1 | 40.98 Million USD | -3.1% |
| 2023 Q3 | 34.94 Million USD | -5.39% |
| 2023 FY | 34.43 Million USD | -18.57% |
| 2022 FY | 42.29 Million USD | -13.14% |
| 2022 Q1 | 48.02 Million USD | -1.36% |
| 2022 Q2 | 45.64 Million USD | -4.95% |
| 2022 Q3 | 44.95 Million USD | -1.51% |
| 2022 Q4 | 42.29 Million USD | -5.94% |
| 2021 Q1 | 49.55 Million USD | 77.19% |
| 2021 Q4 | 48.68 Million USD | -3.67% |
| 2021 FY | 48.68 Million USD | 74.07% |
| 2021 Q3 | 50.54 Million USD | 0.04% |
| 2021 Q2 | 50.52 Million USD | 1.94% |
| 2020 Q3 | 28.45 Million USD | -2.79% |
| 2020 FY | 27.96 Million USD | -19.66% |
| 2020 Q1 | 30.89 Million USD | -11.25% |
| 2020 Q2 | 29.27 Million USD | -5.25% |
| 2020 Q4 | 27.96 Million USD | -1.72% |
| 2019 Q2 | 38.48 Million USD | -5.37% |
| 2019 FY | 34.81 Million USD | -16.46% |
| 2019 Q4 | 34.81 Million USD | -3.18% |
| 2019 Q3 | 35.95 Million USD | -6.57% |
| 2019 Q1 | 40.66 Million USD | -2.41% |
| 2018 Q3 | 43.53 Million USD | 23.89% |
| 2018 Q4 | 41.67 Million USD | -4.28% |
| 2018 Q2 | 35.14 Million USD | -5.56% |
| 2018 FY | 41.67 Million USD | 0.06% |
| 2018 Q1 | 37.21 Million USD | -10.65% |
| 2017 Q1 | 47.42 Million USD | -1.49% |
| 2017 Q3 | 43.61 Million USD | -4.75% |
| 2017 Q4 | 41.64 Million USD | -4.5% |
| 2017 FY | 41.64 Million USD | -13.5% |
| 2017 Q2 | 45.78 Million USD | -3.46% |
| 2016 Q3 | 42.71 Million USD | -2.36% |
| 2016 Q2 | 43.74 Million USD | 3.26% |
| 2016 Q1 | 42.36 Million USD | 1.29% |
| 2016 FY | 48.14 Million USD | 15.11% |
| 2016 Q4 | 48.14 Million USD | 12.71% |
| 2015 Q4 | 41.82 Million USD | 2.88% |
| 2015 Q2 | 41.16 Million USD | -2.56% |
| 2015 Q3 | 40.65 Million USD | -1.25% |
| 2015 FY | 41.82 Million USD | 0.01% |
| 2015 Q1 | 42.25 Million USD | 1.03% |
| 2014 Q1 | 32.98 Million USD | -2.07% |
| 2014 Q2 | 32.26 Million USD | -2.17% |
| 2014 FY | 41.81 Million USD | 24.17% |
| 2014 Q3 | 32.57 Million USD | 0.98% |
| 2014 Q4 | 41.81 Million USD | 28.36% |
| 2013 Q3 | 32.03 Million USD | 2.13% |
| 2013 Q1 | 29.15 Million USD | 0.83% |
| 2013 Q2 | 31.37 Million USD | 7.61% |
| 2013 FY | 33.67 Million USD | 16.48% |
| 2013 Q4 | 33.67 Million USD | 5.12% |
| 2012 FY | 28.91 Million USD | -10.07% |
| 2012 Q4 | 28.91 Million USD | -5.02% |
| 2012 Q3 | 30.43 Million USD | -2.73% |
| 2012 Q2 | 31.29 Million USD | 1.21% |
| 2012 Q1 | 30.91 Million USD | -3.83% |
| 2011 FY | 32.14 Million USD | 10.02% |
| 2011 Q1 | 29.3 Million USD | 0.29% |
| 2011 Q4 | 32.14 Million USD | 4.16% |
| 2011 Q3 | 30.86 Million USD | 3.31% |
| 2011 Q2 | 29.87 Million USD | 1.95% |
| 2010 Q4 | 29.22 Million USD | 3.62% |
| 2010 Q2 | 26.64 Million USD | 4.8% |
| 2010 Q1 | 25.42 Million USD | -10.12% |
| 2010 Q3 | 28.2 Million USD | 5.82% |
| 2010 FY | 29.22 Million USD | 3.28% |
| 2009 Q4 | 28.29 Million USD | 3.54% |
| 2009 Q2 | 26.91 Million USD | -2.35% |
| 2009 FY | 28.29 Million USD | 0.23% |
| 2009 Q1 | 27.56 Million USD | -2.34% |
| 2009 Q3 | 27.32 Million USD | 1.51% |
| 2008 Q4 | 28.22 Million USD | -21.06% |
| 2008 Q2 | 38.87 Million USD | -2.61% |
| 2008 FY | 28.22 Million USD | -39.5% |
| 2008 Q1 | 39.92 Million USD | -14.43% |
| 2008 Q3 | 35.75 Million USD | -8.03% |
| 2007 Q3 | 60.55 Million USD | -3.84% |
| 2007 Q4 | 46.65 Million USD | -22.95% |
| 2007 FY | 46.65 Million USD | 16.12% |
| 2007 Q1 | 64.42 Million USD | 60.35% |
| 2007 Q2 | 62.96 Million USD | -2.26% |
| 2006 Q4 | 40.17 Million USD | -2.74% |
| 2006 FY | 40.17 Million USD | -2.26% |
| 2006 Q1 | 40.99 Million USD | -0.26% |
| 2006 Q2 | 41.52 Million USD | 1.3% |
| 2006 Q3 | 41.3 Million USD | -0.53% |
| 2005 FY | 41.1 Million USD | 5.14% |
| 2005 Q3 | 40.93 Million USD | 3.16% |
| 2005 Q4 | 41.1 Million USD | 0.41% |
| 2005 Q1 | 38 Million USD | -2.78% |
| 2005 Q2 | 39.68 Million USD | 4.41% |
| 2004 Q3 | 37.65 Million USD | 2.0% |
| 2004 Q4 | 39.09 Million USD | 3.82% |
| 2004 Q2 | 36.91 Million USD | 2.91% |
| 2004 Q1 | 35.87 Million USD | 0.1% |
| 2004 FY | 39.09 Million USD | 9.08% |
| 2003 Q3 | 34.47 Million USD | 1.3% |
| 2003 Q4 | 35.83 Million USD | 3.96% |
| 2003 Q2 | 34.03 Million USD | -1.45% |
| 2003 FY | 35.83 Million USD | 4.57% |
| 2003 Q1 | 34.53 Million USD | 0.76% |
| 2002 FY | 34.27 Million USD | 1.43% |
| 2002 Q1 | 32.63 Million USD | -3.42% |
| 2002 Q2 | 32.58 Million USD | -0.15% |
| 2002 Q3 | 33.43 Million USD | 2.63% |
| 2002 Q4 | 34.27 Million USD | 2.49% |
| 2001 Q2 | 32.3 Million USD | 0.94% |
| 2001 Q3 | 32.63 Million USD | 1.04% |
| 2001 Q4 | 33.78 Million USD | 3.52% |
| 2001 FY | 33.78 Million USD | -3.53% |
| 2001 Q1 | 32 Million USD | -8.63% |
| 2000 Q4 | 35.02 Million USD | -0.78% |
| 2000 Q1 | 33.2 Million USD | 1.66% |
| 2000 Q2 | 34.64 Million USD | 4.33% |
| 2000 Q3 | 35.3 Million USD | 1.89% |
| 2000 FY | 35.02 Million USD | 7.22% |
| 1999 Q1 | 28.8 Million USD | 1.41% |
| 1999 FY | 32.66 Million USD | 15.02% |
| 1999 Q2 | 29.4 Million USD | 2.08% |
| 1999 Q3 | 30.1 Million USD | 2.38% |
| 1999 Q4 | 32.66 Million USD | 8.52% |
| 1998 Q3 | 27.8 Million USD | -0.36% |
| 1998 FY | 28.4 Million USD | 6.37% |
| 1998 Q1 | 27.7 Million USD | 3.75% |
| 1998 Q2 | 27.9 Million USD | 0.72% |
| 1998 Q4 | 28.4 Million USD | 2.16% |
| 1997 FY | 26.7 Million USD | 12.66% |
| 1997 Q1 | 23 Million USD | -2.95% |
| 1997 Q2 | 24.7 Million USD | 7.39% |
| 1997 Q3 | 25.4 Million USD | 2.83% |
| 1997 Q4 | 26.7 Million USD | 5.12% |
| 1996 Q3 | 22.5 Million USD | 0.9% |
| 1996 Q4 | 23.7 Million USD | 5.33% |
| 1996 FY | 23.7 Million USD | 270.31% |
| 1996 Q2 | 22.3 Million USD | 0.0% |
| 1995 Q4 | 6.4 Million USD | 0.0% |
| 1995 FY | 6.4 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -9.788% |
| BrainsWay Ltd. | 62.97 Million USD | 45.315% |
| Cerus Corporation | 197.74 Million USD | 82.586% |
| Envoy Medical, Inc. | 7.64 Million USD | -350.733% |
| electroCore, Inc. | 16.38 Million USD | -110.142% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -347.686% |
| IceCure Medical Ltd | 16.41 Million USD | -109.848% |
| Inogen, Inc. | 326.19 Million USD | 89.443% |
| OrthoPediatrics Corp. | 449.58 Million USD | 92.341% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -26.278% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -107.708% |
| MaxCyte, Inc. | 268.27 Million USD | 87.164% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -325.277% |
| Nexalin Technology, Inc. | 3.63 Million USD | -848.15% |
| Orthofix Medical Inc. | 925.31 Million USD | 96.278% |
| PAVmed Inc | 33.11 Million USD | -3.977% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 75.995% |
| RxSight, Inc. | 182.55 Million USD | 81.136% |
| Sight Sciences, Inc. | 166.65 Million USD | 79.336% |
| SI-BONE, Inc. | 230.42 Million USD | 85.055% |
| TELA Bio, Inc. | 78.04 Million USD | 55.878% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 86.33% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -220.932% |
| Acutus Medical, Inc. | 53.96 Million USD | 36.182% |
| Talis Biomedical Corporation | 98.34 Million USD | 64.983% |
| Spectral AI, Inc. | 10.69 Million USD | -222.073% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 84.25% |
| CVRx, Inc. | 115.22 Million USD | 70.115% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 41.297% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -1005.4% |
| Bioventus Inc. | 810.91 Million USD | 95.753% |
| Venus Concept Inc. | 93.65 Million USD | 63.231% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -33.862% |
| LivaNova PLC | 2.42 Billion USD | 98.583% |
| 908 Devices Inc. | 202.98 Million USD | 83.035% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 95.723% |
| Nemaura Medical Inc. | 14.56 Million USD | -136.458% |
| NeuroPace, Inc. | 107.65 Million USD | 68.011% |
| LENSAR, Inc. | 69.58 Million USD | 50.512% |
| Apyx Medical Corporation | 79.24 Million USD | 56.542% |
| Cutera, Inc. | 346.29 Million USD | 90.056% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 18.041% |
| BioSig Technologies, Inc. | 1.79 Million USD | -1815.239% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 87.276% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 19.28% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.089% |
| Axonics, Inc. | 719.92 Million USD | 95.217% |
| Outset Medical, Inc. | 313.8 Million USD | 89.026% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 91.491% |
| IRadimed Corporation | 92.15 Million USD | 62.633% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -555.424% |
| INVO Bioscience, Inc. | 20.88 Million USD | -64.862% |
| Telesis Bio, Inc. | 70.41 Million USD | 51.093% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 77.654% |
| Varex Imaging Corporation | 1.24 Billion USD | 97.244% |
| Quipt Home Medical Corp. | 247.4 Million USD | 86.081% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -269.882% |
| Pulmonx Corporation | 178.95 Million USD | 80.757% |
| Dynatronics Corporation | 25.94 Million USD | -32.75% |
| Modular Medical, Inc. | 13.8 Million USD | -149.41% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -221.022% |
| Semler Scientific, Inc. | 78.06 Million USD | 55.888% |
| InMode Ltd. | 863.28 Million USD | 96.011% |
| Bruker Corporation | 4.24 Billion USD | 99.19% |
| Cytosorbents Corporation | 53.26 Million USD | 35.344% |
| DexCom, Inc. | 6.26 Billion USD | 99.45% |
| Align Technology, Inc. | 6.08 Billion USD | 99.434% |
| Viveve Medical, Inc. | 25.91 Million USD | -32.891% |
| ZimVie Inc. | 1.2 Billion USD | 97.143% |
| Movano Inc. | 9.42 Million USD | -265.524% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 93.081% |
| Nexalin Technology, Inc. | 3.63 Million USD | -848.15% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 41.297% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 96.385% |
| Profound Medical Corp. | 43.68 Million USD | 21.174% |
| Insulet Corporation | 2.58 Billion USD | 98.67% |
| enVVeno Medical Corporation | 48.63 Million USD | 29.195% |
| Surmodics, Inc. | 185.73 Million USD | 81.459% |
| iCAD, Inc. | 41.41 Million USD | 16.857% |
| Nuwellis, Inc. | 9.77 Million USD | -252.467% |
| Biotricity, Inc. | 5.94 Million USD | -479.475% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 92.05% |
| Aethlon Medical, Inc. | 8.24 Million USD | -317.609% |
| InspireMD, Inc. | 47.64 Million USD | 27.721% |
| PAVmed Inc. | 33.11 Million USD | -3.977% |
| BIOLASE, Inc. | 35.1 Million USD | 1.895% |
| Beyond Air, Inc. | 56.96 Million USD | 39.545% |
| FONAR Corporation | 214.24 Million USD | 83.927% |
| AxoGen, Inc. | 196.82 Million USD | 82.504% |
| Vivani Medical, Inc. | 45.79 Million USD | 24.807% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 87.764% |
| Inari Medical, Inc. | 674.23 Million USD | 94.893% |
| UFP Technologies, Inc. | 404.13 Million USD | 91.479% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -47.171% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -262.365% |
| Tenon Medical, Inc. | 6.34 Million USD | -442.727% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -266.068% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 66.776% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.255% |
| Sintx Technologies, Inc. | 15.36 Million USD | -124.12% |
| NanoVibronix, Inc. | 6.67 Million USD | -415.972% |
| Quanterix Corporation | 425.01 Million USD | 91.898% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -269.882% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 35.906% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 98.028% |
| TransMedics Group, Inc. | 706.04 Million USD | 95.123% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 45.506% |
| NeuroMetrix, Inc. | 21.42 Million USD | -60.732% |
| Hyperfine, Inc. | 94.19 Million USD | 63.443% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 87.181% |
| Biomerica, Inc. | 9.25 Million USD | -272.12% |
| Bone Biologics Corporation | 3.73 Million USD | -821.3% |
| AVITA Medical, Inc. | 144.33 Million USD | 76.142% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -607.318% |
| Silk Road Medical, Inc | 265.3 Million USD | 87.02% |